Similarly, there is not a strict upregulation of markers specific to severe COVID19 (i.e., IFNα1, IFNβ, IFNγ and IL6) relative to control and mild COVID19 for differentially expressed markers generated using the cytokine-specific estimates produced by the irea.pos method (see S28 Fig). The gene discussed is IFNA1; the disease is COVID-19.